SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Clinical trial NCT04480372 · COMPLETED

Trial details

NCT number: NCT04480372
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma Non-small Cell Lung Cancer

Start date: 2021-03-17
Primary completion: 2023-03-10
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.